Toxoplasmosis in Cats: Zoonotic Risks and Clinical Management

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. Felids, including domestic cats (Felis catus), serve as the definitive hosts in which the parasite completes its sexual cycle and produces oocysts [1]. The life cycle involves three infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (within sporulated oocysts) [2]. Cats become infected through ingestion of tissue cysts from intermediate hosts (e.g., rodents, birds) or through ingestion of sporulated oocysts from the environment [3]. Following ingestion, bradyzoites are released in the small intestine, invade enterocytes, and undergo a series of asexual and sexual developmental stages culminating in the production of unsporulated oocysts [1]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has elucidated the transcriptional dynamics of these pre-sexual and sexual stages, revealing distinct cell division patterns [2, 1]. Oocysts are shed in feces for 1 to 3 weeks, typically beginning 3 to 10 days post-infection [4]. Shedding can involve millions of oocysts, which sporulate in the environment within 1 to 5 days under aerobic conditions, becoming infectious to a wide range of warm-blooded intermediate hosts [5].

Epidemiology and Zoonotic Context

T. gondii infection is globally distributed, with seroprevalence in cats varying widely by geographic region, management practices, and lifestyle [6, 3]. A study in Hong Kong reported seroprevalence rates of 28.6% in privately-owned cats and 37.5% in community cats, with demographic factors such as age and outdoor access significantly associated with seropositivity [6]. In Jordan, seroprevalence in cats was found to be 41.2% using a commercial ELISA, with molecular detection of T. gondii DNA in fecal samples confirming active shedding in a subset of animals [3]. Similarly, a study in Bangkok, Thailand, detected T. gondii DNA in 8.3% of fecal samples from stray cats using PCR, underscoring the environmental contamination risk posed by free-roaming feline populations [4].

The term "toxoplasmosis cat lady disease" has emerged in popular discourse, often linking cat ownership, particularly among women, with T. gondii infection. This association is rooted in the parasite's unique biology: cats are the only definitive hosts, and oocyst shedding is a primary source of environmental contamination [5]. However, epidemiological studies indicate that the primary risk factors for human seropositivity are consumption of undercooked meat containing tissue cysts and exposure to contaminated soil or water, rather than direct contact with cats [7, 8]. A study in Brazil found that social marginalisation and environmental degradation were significant predictors of T. gondii exposure in urban informal settlements, highlighting the role of poor sanitation and soil contamination over cat ownership per se [5]. Veterinary professionals and students, who have frequent contact with cats, do not consistently show elevated seroprevalence compared to the general population, suggesting that standard hygiene practices are effective in mitigating occupational risk [7].

The concept of "cat toxoplasmosis brain" refers to the potential neurotropic effects of T. gondii infection in both feline and intermediate hosts. In cats, neurological signs can arise from acute or reactivated infection, particularly in immunocompromised individuals [9]. In intermediate hosts, including humans, latent infection has been associated with altered behaviour and neuropsychiatric outcomes, though the causal mechanisms remain under investigation [10, 11]. A population-based cohort study found an association between childhood T. gondii seropositivity and psychotic experiences, as well as reduced grey matter volume, suggesting a potential neurodevelopmental impact [10]. Experimental studies have demonstrated that T. gondii can manipulate host behaviour, potentially enhancing transmission to the definitive feline host [11].

Clinical Signs and Pathology in Cats

Feline toxoplasmosis can present as subclinical, mild, or severe disease, depending on the host's immune status, parasite strain, and route of infection [9]. Clinical signs are most commonly observed in young kittens and immunocompromised adults, including those co-infected with feline immunodeficiency virus or feline leukemia virus [12]. The most frequently affected organ systems are the respiratory, gastrointestinal, hepatic, and nervous systems [9].

Ocular toxoplasmosis is a common manifestation in cats, presenting as uveitis, chorioretinitis, and anterior chamber inflammation [13]. Neurological signs, associated with "cat toxoplasmosis brain", include ataxia, seizures, circling, behavioural changes, and cranial nerve deficits [9]. A study of 72 cats with pyogranulomatous and neutrophilic lymphadenitis identified T. gondii as a differential diagnosis in cases of systemic infection, with lymph node enlargement being a notable clinical finding [9]. Hepatic involvement can lead to icterus and elevated liver enzymes, while pulmonary infection causes dyspnea and coughing due to interstitial pneumonia [12].

Pathologically, T. gondii infection in cats is characterised by necrotising and inflammatory lesions in affected tissues. Tachyzoites and tissue cysts can be identified histologically in the brain, heart, liver, lungs, and skeletal muscle [14]. In the small intestine, the site of sexual replication, microRNA expression profiles are dynamically altered during infection, reflecting host-parasite interactions at the mucosal interface [15]. The AB blood group system phenotype in cats does not appear to play a role in susceptibility to T. gondii infection [16].

Diagnostics

Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods. Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most common screening approach [17, 18]. Commercial ELISA kits are widely used for detecting antibodies in serum or plasma [6, 3]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed and field-validated for detection of T. gondii antibodies in multiple host species, including cats, offering a rapid point-of-care diagnostic tool [17]. Similarly, a SAG1-based colloidal gold immunochromatographic strip has been developed for swine but has potential cross-species applicability [18].

Molecular diagnostics, particularly PCR, are used to detect T. gondii DNA in biological samples, including blood, cerebrospinal fluid, aqueous humor, and feces [4, 19]. An antisense PCR assay has been developed and evaluated specifically for T. gondii detection in domestic cats, demonstrating improved sensitivity compared to conventional PCR by targeting the highly repetitive 529 bp element [19]. PCR detection of T. gondii DNA in fecal samples is valuable for identifying actively shedding cats, though the intermittent nature of oocyst excretion can lead to false negatives [4].

Histopathological examination of biopsy or necropsy tissues can reveal characteristic lesions and identify tachyzoites or tissue cysts [14]. Immunohistochemistry using antibodies against T. gondii antigens enhances detection sensitivity in tissue sections [14]. The MIC17A antigen has shown potential as both an entero-epithelial and chronic stage marker for detection of feline toxoplasmosis, offering a novel target for serological and molecular assays [20].

The following table summarises the primary diagnostic modalities for feline toxoplasmosis:

Treatment and Clinical Management

Treatment of clinical toxoplasmosis in cats is indicated when signs of active disease are present. The standard therapeutic regimen consists of clindamycin administered orally or parenterally at a dosage of 10 to 12 mg/kg every 12 hours for 2 to 4 weeks [9]. Alternative therapies include trimethoprim-sulfonamide combinations and pyrimethamine, though these are less commonly used in cats due to potential adverse effects [12]. Supportive care, including fluid therapy, nutritional support, and anti-inflammatory medications (e.g., corticosteroids for ocular inflammation), is essential in severe cases [13].

For cats with neurological signs ("cat toxoplasmosis brain"), clindamycin remains the first-line agent, though its penetration of the blood-brain barrier is limited [9]. In cases of ocular toxoplasmosis, topical corticosteroids may be used in conjunction with systemic antiprotozoal therapy to control inflammation [13]. Treatment should be continued until clinical signs resolve, and follow-up serology or PCR may be used to monitor response [19].

Zoonotic Risk and Prevention

The zoonotic risk of T. gondii from cats is primarily associated with the ingestion of sporulated oocysts from contaminated environments [5, 4]. Cats typically shed oocysts for only a short period (1 to 3 weeks) after primary infection, and re-shedding is rare unless the cat is immunocompromised or re-infected [3]. Therefore, the risk of acquiring toxoplasmosis from a single cat is relatively low, provided basic hygiene measures are followed [21].

Prevention strategies for cat owners include: keeping cats indoors to prevent hunting and ingestion of intermediate hosts; feeding commercially processed or cooked food rather than raw meat; daily cleaning of litter boxes (oocysts require 1 to 5 days to sporulate and become infectious); and wearing gloves when handling soil or gardening in areas potentially contaminated with cat feces [21]. Pregnant women and immunocompromised individuals should avoid handling litter boxes and should practice rigorous hand hygiene [22, 21]. A study in Côte d'Ivoire found that knowledge and practices towards toxoplasmosis among pregnant women in primary care were suboptimal, highlighting the need for targeted education [22].

The public health significance of T. gondii extends beyond direct cat-to-human transmission. Contamination of water sources and soil with oocysts can lead to outbreaks of toxoplasmosis in human populations, particularly in regions with poor sanitation [5, 8]. Livestock, including pigs, sheep, and goats, can become infected through ingestion of oocysts, leading to the presence of tissue cysts in meat products [8, 23]. A study in eastern Spain found low seroprevalence of T. gondii in pig farms with controlled animal entry, indicating that biosecurity measures can reduce infection risk in livestock [23]. In goats, infection is associated with abortion and stillbirth, with molecular and histopathological detection of T. gondii in aborted fetal myocardium [14]. Similarly, T. gondii has been detected in aborted equine fetuses, and serological evidence of infection has been found in mares enrolled in embryo transfer programs [24].

Control and Vaccine Development

Control of T. gondii infection in cats and other hosts relies on a combination of management practices, hygiene, and, potentially, vaccination. No commercial vaccine is currently available for cats, though significant progress has been made in developing gene-edited live-attenuated vaccines [25, 26]. Recent advances include the use of CRISPR/Cas9 technology to delete genes essential for virulence or persistence, creating attenuated strains that induce protective immunity without causing disease [25]. These vaccines have shown promise in animal models, but challenges remain in terms of safety, stability, and regulatory approval [26]. mRNA-based vaccines, leveraging the success of SARS-CoV-2 vaccines, are also being explored for T. gondii as part of a One Health strategy [26].

The following Mermaid diagram illustrates a clinical decision tree for the management of suspected toxoplasmosis in cats:

flowchart TD
    A[Cat presents with clinical signs: fever, uveitis, neurological deficits, lymphadenopathy], > B{Serology (ELISA) for anti-T. gondii IgG/IgM}
    B, >|IgM positive or rising IgG| C[Active infection suspected]
    B, >|IgG positive only| D[Chronic/latent infection]
    B, >|Negative| E[Consider other differentials]
    C, > F{Confirm with PCR on blood, CSF, or aqueous humor}
    F, >|PCR positive| G[Initiate clindamycin therapy]
    F, >|PCR negative| H[Re-evaluate clinical signs; consider histopathology]
    G, > I[Monitor clinical response over 2-4 weeks]
    I, >|Improvement| J[Complete course; follow-up serology]
    I, >|No improvement| K[Re-assess diagnosis; consider alternative therapies]
    D, > L[No treatment indicated unless immunocompromised or reactivation suspected]
    L, > M[Monitor for clinical signs; advise on zoonotic risk reduction]

Conclusion

Toxoplasmosis in cats remains a significant veterinary and public health concern due to the parasite's unique life cycle, zoonotic potential, and ability to cause severe clinical disease in susceptible hosts. The association between cats and human toxoplasmosis, often colloquially termed "toxoplasmosis cat lady disease", is epidemiologically nuanced, with environmental contamination and foodborne transmission playing larger roles than direct cat contact. The neurotropic nature of T. gondii, encapsulated in the concept of "cat toxoplasmosis brain", underscores the importance of understanding host-parasite interactions at the molecular and cellular level. Advances in diagnostics, including immunochromatographic strips and antisense PCR, have improved detection capabilities, while gene-edited live-attenuated vaccines offer hope for future control. Veterinary professionals play a critical role in educating cat owners about zoonotic risk reduction, implementing appropriate diagnostic and therapeutic protocols, and contributing to One Health surveillance efforts.

References

[1] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[2] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[3] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[4] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[5] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[6] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[7] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[8] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[9] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a referral hospital: with a focus on nine cats with steroid-responsive lymphadenitis. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41527158/

[10] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[11] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41481062/

[12] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[13] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[14] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[15] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[16] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[17] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[18] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[19] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[20] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[21] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[22] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[23] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[24] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[25] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[26] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[27] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[28] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[29] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[30] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[31] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[32] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[33] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[34] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/

[35] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/